Annual Congress of the European Association for Cancer Research (EACR) 2024
Event Overview
The 2024 Annual Congress of the European Association for Cancer Research (EACR 2024) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
Meet the NanoString team by visiting booth #23.
Would you like to book a meeting with a team member? Please contact Irene Yujnovsky.
NanoString Symposium | Monday 10th June | 13:15 – 14:00 PM | Port Room
Highest-plex Spatial Multi-omics – Eliminating the Blind Spots in Your Research
Explore the current landscape and future prospects of spatial biology at our upcoming symposium. We will reveal the latest advancements in product technology including the GeoMx® IO Proteome Atlas, an innovative solution allowing the profiling of over 570 proteins within precise tissue compartments.
Furthermore, Prof. Jamieson will provide an in-depth analysis of his latest results including the use of the CosMx™ Human 6K Discovery Panel, a pioneering solution for profiling over 6,000 genes at single-cell resolution and preserving the biological context. Join us on June 10th to stay updated on these exciting developments!
SYMPOSIUM AGENDA
- 13:15-13:20: Introduction by Irene Yujnovsky, PhD., Sr. Regional Marketing Manager, NanoString.
- 13:20-13:40: Uncovering Spatial Insights in Cancer Research through High-Plex Spatial Multi-Omics by Alyssa Rosenbloom, PhD., Associate Director, R&D, NanoString
- 13:40-14:00: Multi-omic, multi-scale Characterisation of Colorectal Cancer Defines Spatiotemporal Patterns and pathways by Nigel Jamieson, PhD., University of Glasgow
NanoString EACR posters
| Poster # | Abstract # | Session | Date & Time | Poster Title | Presenter | Product |
| 350 | EACR2024-0968 | Translational Research | June 11th 18:40-20:15 | Constructing comprehensive single-cell spatial atlases across multiple FFPE human tissues using a universal 6,000-plex RNA panel | Rudy van Eijsden | CosMx SMI |
| 352 | EACR2024-0972 | Translational Research | June 11th 18:40-20:15 | Comparative biological discoveries between colon cancer and diseased tissues using a novel spatial multiomic approach and a comprehensive Immuno-Oncology Proteome Atlas and Whole Transcriptome Atlas | Irene Yujnovsky | GeoMx DSP |
| 397 | EACR2024-0889 | Tumour Biology | June 12th 18:40-20:15 | Ultra highplex spatial proteomic and transcriptomic analysis of the head and neck cancer tumour microenvironment | Alyssa Rosenbloom | GeoMx DSP |
Guardians of the Omics Galaxy photo contest
Become a Guardian of the ‘Omics Galaxy Defenders of Plex and Gene Expression!
As part of the NanoString Guardian of the ‘Omics Galaxy photo contest, post your superhero photo onto your social media channels with #NanoString #EACR2024, all participants will be entered into a raffle to win our grand prize of a Polaroid camera bundle.
Take a selfie and let AI create your NanoString Guardian of the Omics Galaxy social media post to enter a raffle to win a Polaroid Instant Camara Bundle (terms and conditions apply).
Scan the QR code on the right to Get Your Superhero Photo
The CosMx™ SMI and decoder probes are not offered and/or delivered to the Federal Republic of Germany for use in the Federal Republic of Germany for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof in a method used in fluorescence in situ hybridization for detecting a plurality of analytes in a sample without the consent of the President and Fellows of Harvard College (Harvard Corporation) as owner of the German part of EP 2 794 928 B1. The use for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof is prohibited without the consent of the President and Fellows of Harvard College (Harvard Corporation).
Speakers
Alyssa Rosenbloom, PhD
Associate Director Research, NanoString
Nigel Jamieson MD PhD
Clinical Senior Lecturer and Consultant HPB Surgeon; Clinician Scientist, Cancer Research UK; School of Cancer Sciences, Glasgow Royal Infirmary, University of Glasgow
Nigel Jamieson is a Clinical Senior Lecturer within the Institute of Cancer Sciences and an Honorary Consultant HPB surgeon at Glasgow Royal Infirmary. He has contributed to over 130 peer reviewed publications and has an active role in the development and management of the Precision-Panc platform; his laboratory group focuses on the interaction between the immune microenvironment and chemotherapy in the tumors of patients with pancreatic cancer and has established a spatial transcriptomic facility characterizing multiple malignancies, premalignant lesions, and inflammatory conditions. He works closely with Pancreatic Cancer UK and is part of a national group aiming to standardize care for patients with pancreatic cancer across the UK.
